|
Etiology
Acute bronchitis is rarely caused by atypical
bacteria such as C. pneumoniae and M. pneumoniae, and rarely caused
by bacterial infections severe enough significantly to increase the
level of C-reactive protein.
-
Caveats
-
Age group studied: Age 16 y and over
-
Type/size: Prospective study (113 patients)
-
Population characteristics: General parctice
population
-
Diagnostic criteria: Coughing with or without
expectorationk with ronchi or widespread crepitations on auscultation,
and without any underlying lung disease or clinical signs of pneumonia
-
Outcome measures: Serology for Chlamydia pneumoniae,
Mycoplasma pneumoniae, respiratory tract viruses, level of C-reactive protein
-
Citations
Epidemiology
No evidence is cited.
Diagnosis
Of patients presenting with chronic cough,
92% had gastroesophageal reflux disease (GERD), postnasal drip syndrome,
and/or asthma. Considering only patients with cough of at least
3 weeks duration who are non-smokers, are not receiving angiotensin-converting
enzyme (ACE) inhibitors, and have normal
or nearly normal and stable chest radiographs, 99.4% will have GERD, postnasal
drip syndrome, and/or asthma. Only 39% had a single cause of cough.
-
Caveats
-
Age group studied: Mean age 53.1 years
-
Type/size: Population study of 88 patients
-
Population characteristics: Immunocompetent
patients who were referred to a pulmonary outpatient clinic for evaluation
of chronic cough, average duration of cough was 6.6 years, 27% were male
-
Outcome measures: Relationship between the
patient's symptoms and the final diagnosis or diagnoses
-
Citations
Treatment
Antibiotics
Doxycycline, erythromycin and trimethoprim/sulfamethoxazole
appear to have, at best, a modest beneficial effect in the treatment of
acute bronchitis, with a corresponding small risk of adverse effects. Antibiotic
treated groups tended to be either no less likely or slightly less likely
to report feeling unwell at a follow up visit, to show no improvement on
physician assessment or to have abnormal lung findings, and had a more
rapid return to work or usual activities. Antibiotic- treated patients
reported significantly more adverse effects such as nausea, vomiting, headache,
skin rash or vaginitis.
-
Caveats
-
Age group studied: 8y-65+y
-
Outcome measure: Symptom improvement and return
to work
-
The benefits of antibiotics may be overestimated
in the Cochrane analysis, however, because of the tendency of published
reports to include complete data on only the outcomes found to be statistically
significant.
-
CRD study slightly limited by the lack of
information on the included patients, the quality of the
included studies and absence of statistical
differences in some studies may have been due to the small sample sizes.
-
Citations
Cefprozil, cefpodoxime proxetil, loracarbef,
cefixime, and ceftibuten were compared to conventional antibiotic
therapies (usually amoxicillin/clavulanate, cefaclor or cephalexin)
for community acquired infections. Infections included acute otitis media,
pharyngitis, sinusitis, bronchitis, pneumonia, urinary tract infection
and skin and skin-structure infections. The newer agents appear to be as
clinically effective as conventional therapies (but not more effective)
for the treatment of common community-acquired infections. They may also
have the potential to improve compliance due to their once/twice daily
mode of
administration.
-
Caveats
-
Age group studied: Unknown
-
Type/size: Analytical review of studies: acute
otitis media: 19 studies, pharyngitis: 13 studies, sinusitis: 4 studies,
bronchitis: 10 studies, pneumonia: 7 studies, urinary tract infection:
11 studies, skin and skin-structure infections: 4 studies. Most studies
consisted of 30-50 patients in each arm
-
Population: Unknown
-
Outcome measure: Clinical response to therapy
-
For some of these infections other studies
show that there is no evidence that any antibiotic therapy is beneficial
-
Citations
Under most circumstances, the most cost-effective
strategy for treating acute bronchitis is to withhold antibiotics
and treat only patients whose cough does not resolve.
-
Caveats
-
Age group studied: N/A
-
Type/size: Cost-effectiveness analysis
-
Population characteristics: N/A
-
Outcome measures: Cost per person in whom
acute bronchitis was diagnosed
-
Citations
Receiving a prescription for an antibiotic
for a URI was not associated with increased patient satisfaction. Better
to spend time explaining the nature of a particular illness and the physician's
choice of treatment.
-
Caveats
-
Age group: Adults
-
Type/size: RCT of 113
-
Outcome measure: Patient satisfaction
-
Diagnostic criteria unclear
-
Citations
Bronchodilators
There is a modest benefit from inhaled
(preferred) or liquid albuterol, in terms of reduced duration of
cough and a quicker return to work, particularly in patients with purulent
secretions.
-
Caveats
-
Age group studied: Adults
-
Outcome measure: Symptom improvement and return
to work
-
Small number of studies and patients
-
Citations
Monitoring
No evidence is cited.
Prognosis
Informational handouts which describe
the purpose and natural history of coughs can lower the rate of return
visits for lower respiratory tract symptoms.
-
Caveats
-
Age group studied: Median age 45y
-
Type/size: 1014 patients
-
Population characteristics: Patients presenting
to GPs' offices with a new cough with at least one of the following: sputum
production, wheeze, or chest pain; 60% females, 31% smokers, 72% were given
antibiotics
-
Outcome measure: Rate at which patients with
lower respiratory illness return for the same symptoms within one month
-
Citations
Prevention
No evidence is cited.
Patient Education
The following patient education materials
are consistent with the available evidence.
Rev.
7/11/01
|